Access the full text.
Sign up today, get DeepDyve free for 14 days.
N.M. Galeeva (2006)
Molecular and Genetic Causes of Hereditary Methemoglobinemia Type I in the Republic of Sakha (Yakutiya)Klin. Genet., 5
T. Dörk, M. Macek, F. Mekus (2000)
Characterization of a Novel 21-Kb Deletion, CFTRdele2.3(21 Kb), in the CFTR Gene: A Cystic Fibrosis Mutation of Slavic Origin Common in Central and East EuropeHum. Genet., 106
Y.S. Wu, Y. Wang, C.H. Huang (2000)
A Compound Heterozygote in the NADH-Cytochrome b5 Reductase Gene from a Chinese Patient with Hereditary Methemoglobinemia Type IInt. J. Hematol., 72
Fermo, P. Bianchi, C. Vercellati (2008)
Recessive Hereditary Methemoglobinemia: Two Novel Mutations in the NADH-Cytochrome b5 Reductase GeneBlood Cells Mol. Dis., 41
C. Junien, M. Vibert, D. Weil (1978)
Assignment of NADH-Cytochrome b5 Reductase (DIA1 Locus) to Human Chromosome 22Hum. Genet., 42
T. Katsube, N. Sakamoto, Y. Kobayashi (1991)
Exonic Point Mutations in NADH-Cytochrome b5 Reductase Genes of Homozygotes for Hereditary Methemoglobinemia, Types I and III: Putative Mechanisms of Tissue-Dependent Enzyme DeficiencyAm. J. Hum. Genet., 48
W. Kugler, A. Pekrun, P. Laspe (2001)
Molecular Basis of Recessive Congenital Methemoglobinemia, Types I and II: Exon Skipping and Three Novel Missense Mutations in the NADH-Cytochrome b5 Reductase (Diaphorase 1) GeneHum. Mutat., 17
G. Pietrini, D. Aggujaro, P. Carrera (1992)
A Single mRNA, Transcribed from an Alternative, Erythroid-Specific, Promoter, Codes for Two Non-Myristylated Forms of NADH-Cytochrome b5 ReductaseJ. Cell Biol., 117
E.P. Owen, J. Berens, A.M. Marinaki (1997)
Recessive Congenital Methaemoglobinaemia Type II a New Mutation Which Causes Incorrect Splicing in the NADH-Cytochrome b5 Reductase GeneJ. Inherit. Metab. Dis., 20
M.J. Percy, M.J. Gillespie, G. Savage (2002)
Familial Idiopathic Methemoglobinemia Revisited: Original Cases Reveal 2 Novel Mutations in NADH-Cytochrome b5 ReductaseBlood, 100
T. Yubisui, K. Shirabe, M. Takeshita (1991)
Structural Role of Serine 127 in the NADH-Binding Site of Human NADH-Cytochrome b5 ReductaseJ. Biol. Chem., 266
A. Leroux, F. Leturcq, N. Deburgrave, M.F. Szajnert (2005)
Prenatal Diagnosis of Recessive Congenital Methaemoglobinaemia Type II: Novel Mutation in the NADH-Cytochrome b5 Reductase Gene Leading to Stop Codon Read-ThroughEur. J. Haematol., 74
M.P. Hudspeth, S. Joseph, K.R. Holden (2010)
A Novel Mutation in Type II MethemoglobinemiaJ. Child Neurol., 25
A. Bulbarelli, A. Valentini, M. DeSilvestris (1998)
An Erythroid-Specific Transcript Generates the Soluble form of NADH-Cytochrome b5 Reductase in HumansBlood, 92
K. Shirabe, T. Yubisui, N. Borgese (1992)
Enzymatic Instability of NADH-Cytochrome b5 Reductase as a Cause of Hereditary Methemoglobinemia Type I (Red Cell Type)J. Biol. Chem., 267
M.M. Jenkins, J.T. Prchal (1996)
A Novel Mutation Found in the 3’ Domain of NADH-Cytochrome b5 Reductase in an African-American Family with Type I Congenital MethemoglobinemiaBlood, 87
M.J. Percy, D. Aslan (2008)
NADH-Cytochrome b5 Reductase in a Turkish Family with Recessive Congenital Methaemoglobinaemia Type IJ. Clin. Pathol., 61
K. Higasa, J.I. Manabe, T. Yubisui (1998)
Molecular Basis of Hereditary Methaemoglobinaemia, Types I and II: Two Novel Mutations in the NADH-Cytochrome b5 Reductase GeneBr. J. Haematol., 103
Y. Wu, C. Huang, Z. Zhu (1998)
Leu 72 Pro Mutation in the NADH-Cytochrome b5 Reductase Gene Found in a Chinese Hereditary Methemoglobinemia PatientZhonghua Xue Ye Xue Za Zhi, 19
D. Grabowska, D. Plochocka, E. Jablonska-Skwiecinska (2003)
Compound Heterozygosity of Two Missense Mutations in the NADH-Cytochrome b5 Reductase Gene of a Polish Patient with Type I Recessive Congenital MethaemoglobinaemiaEur. J. Haematol., 70
S.P. Toelle, E. Boltshayser, E. Mossner (2004)
Severe Neurological Impairment in Hereditary Methemoglobinemia Type 2Eur. J. Pediatr., 163
L.M. Vieira, J.C. Kaplan, A. Kahn, A. Leroux (1995)
Four New Mutations in the NADH-Cytochrome b5 Reductase Gene from Patients with Recessive Congenital Methemoglobinemia Type IBlood, 85
K. Shirabe, Y. Fujimoto, T. Yubisui, M. Takeshita (1994)
An In-Frame Deletion of Codon 298 of the NADH-Cytochrome b5 Reductase Gene Results in Hereditary Methemoglobinemia Type II (Generalized Type): A Functional Implication for the Role of the COOH-Terminal Region of the EnzymeJ. Biol. Chem., 269
Y. Kobayashi, Y. Fukumaki, T. Yubisui (1990)
Serine-Proline Replacement at Residue 127 of NADH-Cytochrome b5 Reductase Causes Hereditary Methemoglobinemia, Generalized TypeBlood, 75
R.H. Nussenzveig, H.B. Lingam, A. Gaikwad (2006)
A Novel Mutation of the Cytochrome-b5 Reductase Gene in an Indian Patient: The Molecular Basis of Type I MethemoglobinemiaHaematologica, 91
M.J. Percy, L.J. Crowley, D. Roper (2006)
Identification and Characterization of the Novel FAD-Binding Lobe G75S Mutation in Cytochrome b5 Reductase: An Aid to Determine Recessive Congenital Methemoglobinemia Status in an InfantBlood Cells Mol. Dis., 36
S. Tomatsu, Y. Kobayashi, Y. Fukumaki (1989)
The Organization and the Complete Nucleotide Sequence of the Human NADH-Cytochrome b5 Reductase GeneGene, 80
E.M. Scott (1960)
The Relation of Diaphorase of Human Erythrocytes to Inheritance of MethemoglobinemiaJ. Clin. Invest., 39
R.A. Fisher, Y.H. Edwards, W. Putt (1977)
An Interpretation of Human Diaphorase Isozymes in Terms of Three Gene Loci DIA1, DIA2 and DIA3Ann. Hum. Genet., 41
F.V. Lorenzo, J.D. Phillips (2011)
Molecular Basis of Two Novel Mutations Found in Type I MethemoglobinemiaBlood Cells Mol. Dis., 46
M.J. Percy, L.J. Crowley, J. Boudreaux, M.J. Barber (2006)
Expression of a Novel P275L Variant of NADH:Cytochrome b5 Reductase Gives Functional Insight into the Conserved Motif Important for Pyridine Nucleotide BindingArch. Biochem. Biophys., 447
C.M. Aalfs, G.B. Salieb-Beugelaar, J.A. Ronald (2000)
A Case of Methemoglobinemia Type II Due to NADH-Cytochrome b5 Reductase Deficiency: Determination of the Molecular BasisHum. Mutat., 16
K. Shirabe, M. Landi, M. Takeshita (1995)
A Novel Point Mutation in a 3′ Splice Site of the NADH Cytochrome b5 Reductase Gene Results in Immunologically Undetectable Enzyme and Impaired NADH-Dependent Ascorbate Regeneration in Cultured Fibroblasts of a Patient with Type II Hereditary MethemoglobinemiaAm. J. Hum. Genet., 57
M.J. Percy, H. Oren, G. Savage, G. Irken (2004)
Congenital Methaemoglobinaemia Type I in a Turkish Infant Due to a Novel Mutation, Pro144Ser, in NADH-Cytochrome b5 ReductaseHematol. J., 5
J. Maran, Y. Guan, C. Ou, J.T. Prchal (2005)
Heterogeneity of the Molecular Biology of Methemoglobinemia: A Study of Eight Consecutive PatientsHaematologica, 90
J. Manabe, R. Arya, H. Sumimoto (1996)
Two Novel Mutations in the Reduced Nicotinamide Adenine Dinucleotide (NADH)-Cytochrome b5 Reductase Gene of a Patient with Generalized Type, Hereditary MethemoglobinemiaBlood, 88
T. Arkoglu, N. Yarali, A. Kara (2009)
A Novel L218P Mutation in NADH-Cytochrome b5 Reductase Associated with Type I Recessive Congenital MethemoglobinemiaPediatr. Hematol. Oncol., 26
R.A. Fisher, S. Povey, M. Bobrow (1977)
Assignment of the DIA1 Locus to Chromosome 22Ann. Hum. Genet., 41
M.J. Percy, L.J. Crowley, C.A. Davis (2005)
Recessive Congenital Methaemoglobinaemia: Functional Characterization of the Novel D239G Mutation in the NADH-Binding Lobe of Cytochrome b5 ReductaseBr. J. Haematol., 129
D. Yilmaz, O. Cogulu, F. Ozkinay, K. Kavakli (2005)
A Novel Mutation in the DIA1 Gene in a Patient with Methemoglobinemia Type IIAm. J. Med. Genet., 133A
J. Dekker, M.H. Eppink, R. Zwieten (2001)
Seven New Mutations in the Nicotinamide Adenine Dinucleotide Reduced-Cytochrome b(5) Reductase Gene Leading to Methemoglobinemia Type IBlood, 97
Hereditary types I and II methemoglobinemia is a rare autosomal recessive disease due to a deficiency of either soluble or soluble and membrane-bound forms of the enzyme NADH-cytochrome b5 reductase. The molecular genetic bases of both types of the disease consist in changes in the CYB5R3 gene. In this study, the novel and, to date, only large deletion in this gene is described, discovered in two unrelated families with types I and II methemoglobinemia. The common founder haplotype on the chromosomes carrying this mutation was identified. A universal approach for searching for the deletion boundaries was developed, and the c.22-1320_633+1224del deletion breakpoints were determined. In addition, a system for identifying the deletion in heterozygous and homozygous states was designed.
Russian Journal of Genetics – Springer Journals
Published: Nov 17, 2012
Access the full text.
Sign up today, get DeepDyve free for 14 days.